Related Experiment Video

Updated: Jul 16, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer

I Niculescu-Duvaz1, R G Cooper, S M Stribbling

  • 1CRC Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, UK.

Current Opinion in Molecular Therapeutics
|November 21, 2001
PubMed

Insights

Gene-directed enzyme prodrug therapy (GDEPT) offers a novel approach to treating solid tumors. This review details advancements in GDEPT systems, vectors, and clinical applications for enhanced cancer treatment.

Area of Science:

  • Oncology
  • Gene Therapy
  • Pharmacology

Background:

  • Gene-directed enzyme prodrug therapy (GDEPT) is a two-step strategy for solid malignant tumors.
  • It involves delivering a foreign enzyme gene to the tumor for subsequent prodrug activation.

Purpose of the Study:

  • To review progress in GDEPT from late 1997 to the present.
  • To outline key developments in vectors, enzyme/prodrug systems, and clinical trials.

Main Methods:

  • Review of scientific literature on GDEPT advancements.
  • Analysis of viral and non-viral vectors, enzyme/prodrug systems, and bystander effects.
  • Comparison of different GDEPT systems and their clinical trial outcomes.

Main Results:

  • Significant progress in viral and non-viral vectors for gene delivery.
  • Development of novel enzyme/prodrug systems and therapeutic strategies.
  • Enhanced understanding of bystander effects and comparative analyses of GDEPT systems.

Conclusions:

  • GDEPT continues to evolve as a promising cancer therapy.
  • Ongoing research focuses on optimizing delivery, efficacy, and safety through various GDEPT strategies.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...